Tevogen Bio (TVGN) Institutional Ownership $1.34 -0.11 (-7.59%) Closing price 01/30/2025 04:00 PM EasternExtended Trading$1.38 +0.03 (+2.61%) As of 04:53 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Tevogen Bio (NASDAQ:TVGN)Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$21.80MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$150.39K Get TVGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Tevogen Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Tevogen Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/24/2025 China Universal Asset Management Co. Ltd.37,117$38K0.0%N/A0.021% 11/15/2024Polar Asset Management Partners Inc.1,577,387$581K0.0%-20.6%0.924% 11/15/2024HGC Investment Management Inc.223,077$82K0.0%N/A0.131% 5/9/2024Portland Global Advisors LLC5,782,209$21.68M3.0%N/A36.550% (Data available from 1/1/2016 forward) TVGN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TVGN shares? During the previous two years, the following institutional investors and hedge funds held shares of Tevogen Bio shares: Portland Global Advisors LLC ($21.68M), Polar Asset Management Partners Inc. ($581K), and HGC Investment Management Inc. ($82K), China Universal Asset Management Co. Ltd. ($38K).Learn more on TVGN's institutional investors. Which institutional investors have been buying Tevogen Bio stock? The following institutional investors have purchased Tevogen Bio stock in the last 24 months: Portland Global Advisors LLC ($5.78M), HGC Investment Management Inc. ($223.08K), and China Universal Asset Management Co. Ltd. ($37.12K). How much institutional buying is happening at Tevogen Bio? Institutional investors have bought a total of 6,042,403 shares in the last 24 months. This purchase volume represents approximately $21.80M in transactions. Which Tevogen Bio major shareholders have been selling company stock? The following institutional investors have sold Tevogen Bio stock in the last 24 months: Polar Asset Management Partners Inc. ($408.23K). How much institutional selling is happening at Tevogen Bio? Institutional investors have sold a total of 408,228 shares in the last 24 months. This volume of shares sold represents approximately $150.39K in transactions. Related Companies Anavex Life Sciences Institutional Ownership Relay Therapeutics Institutional Ownership Sana Biotechnology Institutional Ownership Replimune Group Institutional Ownership Immatics Institutional Ownership Ginkgo Bioworks Institutional Ownership LENZ Therapeutics Institutional Ownership Tectonic Therapeutic Institutional Ownership Cullinan Therapeutics Institutional Ownership Autolus Therapeutics Institutional Ownership This page (NASDAQ:TVGN) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tevogen Bio Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tevogen Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
